Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

3 results

  • Chapter 34 - Transfusion and Anaphylactic and Adverse Drug Reactions in Pregnancy

  • from Section 6 - Anaesthetic Emergencies During Pregnancy
  • Edited by Edwin Chandraharan, Sir Sabaratnam Arulkumaran
  • Book: Obstetric and Intrapartum Emergencies
  • Published online: 06 May 2021
  • Print publication: 03 June 2021, pp 245-251

  • Summary

    Incidence Obstetric blood transfusion represents a small proportion of overall blood use. However, the use of blood products in obstetrics is rising as postpartum haemorrhage rates continue to increase.

    There is evidence of increasing rates of maternal red blood cell transfusion during childbirth worldwide, mainly in the context of postpartum haemorrhage [1–4]. In the United States, there was a steep increase in peripartum transfusion (from 0.3% to 1.0%) between 1998 and 2009 [5].

    Outside the context of major haemorrhage, there is little evidence for the benefit of blood transfusion in fit, healthy, asymptomatic patients. The decision to transfuse must be based on careful clinical assessment in conjunction with the haemoglobin level [6].